Dr Joseph Albert Susi, MD | |
11221 Firethorn Rd, Wattsburg, PA 16442-9754 | |
(814) 739-9206 | |
Not Available |
Full Name | Dr Joseph Albert Susi |
---|---|
Gender | Male |
Speciality | Family Medicine |
Location | 11221 Firethorn Rd, Wattsburg, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1205027638 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | MD025497E (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Joseph Albert Susi, MD 11221 Firethorn Rd, Wattsburg, PA 16442-9754 Ph: (814) 739-9206 | Dr Joseph Albert Susi, MD 11221 Firethorn Rd, Wattsburg, PA 16442-9754 Ph: (814) 739-9206 |
News Archive
Marinus Pharmaceuticals, Inc., the leader in the development of neurosteroids for central nervous system disorders, today announced commencement of a proof-of-concept clinical trial of its lead candidate ganaxolone for the treatment of posttraumatic stress disorder.
Biomedical researchers at Boston University's College of Engineering may have discovered the path toward developing better drugs capable of defeating so-called "superbugs," bacteria that have developed resistance to common antibiotics. The researchers have discovered a previously unknown chain of events occurring in bacteria that opens to door to new avenues of research.
Polyester clothes smell worse than cotton, following intensive exercise by their wearers, because bacteria that cause odor grow better on polyester, according to research published ahead of print in the journal Applied and Environmental Microbiology.
Isis Pharmaceuticals, Inc. and Alnylam Pharmaceuticals, Inc. announced today that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application (No. 10/078,949) in the "Crooke" patent family, which broadly covers chemically modified RNA-containing therapeutics.
In battle with an epidemic that has outpaced nearly all efforts to contain it, researchers are turning to strategies centered on the same antiretroviral (ARV) drugs that have been used successfully to treat HIV in hopes they will be as effective a stronghold for preventing the virus.
› Verified 2 days ago